← Catalog
Retatrutide 20mg

Metabolic

Retatrutide 20mg

Triple agonist: GLP-1 / GIP / Glucagon

Fill
20 mg / vial
Pack
1 vial · 20 mg total
Purity
≥99%
Choose pack size
Price
$100
In stock
Secure checkout COA with every vial Cold-chain shipped

Shipped cold chain with an insulated pack. Orders placed before 2 PM ET are dispatched the same business day.

Retatrutide 20mg
$100
Shipping· Delivery· Returns & refunds

Overview

Triple agonist: GLP-1 / GIP / Glucagon

Retatrutide (LY-3437943) is a synthetic peptide with agonist activity at the GLP-1, GIP and glucagon receptors. Supplied lyophilized as a reference reagent for in-vitro study of incretin and glucagon receptor signaling.

  • Fill: 20 mg / vial
  • Pack: 1 vial · 20 mg total
  • Purity: ≥99%

For in-vitro laboratory research use only. Not for human or animal consumption, medical, diagnostic or therapeutic use.

Receptor pharmacology

GLP-1 and GIP agonism suppress appetite, slow gastric emptying and improve glucose-dependent insulin secretion. The added glucagon receptor agonism drives hepatic energy expenditure and lipolysis, the mechanism that separates retatrutide from semaglutide (GLP-1) and tirzepatide (GLP-1 / GIP).

Laboratory handling

Preparation
Reconstitute for in-vitro use
Half-life
~6 days
Per vial
20 mg / vial · 1 vial · 20 mg total
Purity
≥99%

Research use disclaimer

Sacred Peptides does not provide dosing recommendations for human use. Retatrutide 20mg is supplied for in-vitro laboratory research only. Any concentration ranges referenced on this page or in cited studies describe the parameters used in that research and are not instructions.

  • Not a drug. Not approved by Health Canada or the FDA for human use.
  • Not intended to diagnose, treat, cure, or prevent any disease.
  • Not for use in humans, pregnant or nursing individuals, or animals outside a controlled research setting.
  • Handling, storage, and disposal are the responsibility of a qualified researcher.